Abstract:Radiation therapy prior to surgery has increasingly become the standard of care for locally advanced prostate cancer, however tumor radioresistance remains a major clinical problem. While restoration of microRNA-145 (miR-145) expression reduces chemoradioresistance in glioblastoma and suppress prostate cancer proliferation, migration and invasion, the role of miR-145 in response to radiation therapy for prostate cancer is still unknown. The aim of this study was to investigate the role of miR-145 in determining the tumor response to radiation treatment in prostate cancer. Human prostate cancer cells LNCAP and PC3 were transfected with miR-145 mimic. Clonogenic assay was used to determine whether overexpression of miR-145 could alter radiation response in vitro. Immunofluorescence of γ-H2AX and flow cytometric analysis of phosphorylated histone H3 were performed to investigate the potential mechanisms contributing to the enhanced radiation-induced cell killing induced by miR-145. In addition, a qPCR-based array was used to detect the possible miR-145-mediated regulated genes involved. Tumor growth delay assays and survival curves were then analyzed in an animal model to investigate whether miR-145 induced radiosensitivity in vivo. Furthermore, miR-145 expression was assessed in 30 prostate tumor tissue biopsies taken prior to neoadjuvant radiotherapy using miRNA arrays. Our current study suggested that ectopic expression of miR-145 significantly sensitized prostate cancer cells to radiation and we used γ-H2AX phosphorylation as a surrogate marker of radiotherapy response versus miR-145 expression levels. We observed significantly more foci per cell in the group treated with miR-145 and radiation. In addition, mitotic catastrophe was significantly increased in cells receiving miR-145 and radiation. The above results suggest that miR-145 appears to reduced the efficiency of the repair of radiation-induced DNA double-strand breaks in cells. A detailed examination of the involvement of the DNA repair pathway showed that miR-145 reduced the expression of 10 genes involved in DNA repair according to a qPCR-based array data. Irradiation of subcutaneous PC3 tumors in mice treated with R11-miR-145 (a cellular permeable peptide, previously reported) resulted in an increase in radiation-induced tumor growth delay and lived the longest after combination treatment. Moreover, miR-145 expression was significantly increased in patients demonstrating good response (PSA < 2.0 ng/ml/year) to neoadjuvant radiotherapy, while expression of the miR-145-regulated DNA repair genes was significantly decreased. In conclusion, these data suggest a possible mechanism for miR-145 radiosensitivity, potentially through down regulating of DNA repair. This novel study shows a role for miR-145 in modulating radiosensitivity in vivo and highlights the need for further study investigating the potential role of miR-145 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

253P the Role of MiR-221 in Regulating Gastric Cancer Radiation Sensitivity

The Role of Mir-221 in Regulating Gastric Cancer Radiation Sensitivity

The Role Of Mir-197 In Regulating Gastric Cancer Radiation Sensitivity

Downregulation of Microrna-17-5p Inhibits Drug Resistance of Gastric Cancer Cells Partially Through Targeting P21.

Microrna-219-2-3p Functions As A Tumor Suppressor In Gastric Cancer And Is Regulated By Dna Methylation

MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by inhibiting PTEN expression.

MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT

MiR-181a Confers Resistance of Cervical Cancer to Radiation Therapy Through Targeting the Pro-Apoptotic PRKCD Gene

MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer

Micrornas Expression Profile Related with Response to Preoperative Radiochemotherapy in Patients with Locally Advanced Gastric Cancer

MicroRNA-218 is Upregulated in Gastric Cancer after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Increases Chemosensitivity to Cisplatin

Dysregulation of miRNAs and their potential as biomarkers for the diagnosis of gastric cancer.

Association Of Microrna-181c Expression With The Progression And Prognosis Of Human Gastric Carcinoma

Role of miR-221/222 in Tumor Development and the Underlying Mechanism.

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

MicroRNA-221-3p is Related to Survival and Promotes Tumour Progression in Pancreatic Cancer: a Comprehensive Study on Functions and Clinicopathological Value

MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation

Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells

Enhancement Of Radiotherapy Efficacy By Mir-200c-Loaded Gelatinase-Stimuli Peg-Pep-Pcl Nanoparticles In Gastric Cancer Cells

MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.

MicroRNA-381 Increases Radiosensitivity in Esophageal Squamous Cell Carcinoma.